News Impulse Dynamics secures $30m for novel heart implant Chronic heart failure (CHF) device specialist Impulse Dynamics has secured £30 million in financing.
Articles Digital healthcare round-up: drones, organs-on-chips, diabet... A round-up of this week's top digital healthcare news. Marco Ricci reports.
Oncology Liver cancer diagnostic gets FDA breakthrough status, with P... Mursla Bio CEO and founder Pierre Arséne discusses the breakthrough designation from the FDA for their blood test to catch liver cancer early.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
